[go: up one dir, main page]

EE201300004A - Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks - Google Patents

Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks

Info

Publication number
EE201300004A
EE201300004A EEP201300004A EEP201300004A EE201300004A EE 201300004 A EE201300004 A EE 201300004A EE P201300004 A EEP201300004 A EE P201300004A EE P201300004 A EEP201300004 A EE P201300004A EE 201300004 A EE201300004 A EE 201300004A
Authority
EE
Estonia
Prior art keywords
diseases
treatment
conditions
pharmaceutical composition
cardiovascular system
Prior art date
Application number
EEP201300004A
Other languages
English (en)
Inventor
Iliich Epshtein Oleg
Alexandrovna Sergeeva Svetlana
Fyodorovna Dolgovyh Liudmila
Ivanovich Petrov Vladimir
Original Assignee
Iliich Epshtein Oleg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2010129290/15A external-priority patent/RU2525155C2/ru
Priority claimed from RU2010129291/15A external-priority patent/RU2525156C2/ru
Priority claimed from RU2010129292/15A external-priority patent/RU2523557C2/ru
Priority claimed from RU2011110106/15A external-priority patent/RU2523451C2/ru
Application filed by Iliich Epshtein Oleg filed Critical Iliich Epshtein Oleg
Publication of EE201300004A publication Critical patent/EE201300004A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
EEP201300004A 2010-07-15 2011-07-15 Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks EE201300004A (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2010129290/15A RU2525155C2 (ru) 2010-07-15 2010-07-15 Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для комплексной терапии хронической сердечной недостаточности
RU2010129291/15A RU2525156C2 (ru) 2010-07-15 2010-07-15 Способ лечения и профилактики артериальной гипертензии и фармацевтическая композиция для лечения артериальной гипертензии
RU2010129292/15A RU2523557C2 (ru) 2010-07-15 2010-07-15 Способ лечения вегетососудистой дистонии и фармацевтическая композиция для лечения вегетососудистой дистонии
RU2011110106/15A RU2523451C2 (ru) 2011-03-17 2011-03-17 Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для лечения хронической сердечной недостаточности
PCT/IB2011/002391 WO2012007846A2 (en) 2010-07-15 2011-07-15 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system

Publications (1)

Publication Number Publication Date
EE201300004A true EE201300004A (et) 2013-08-15

Family

ID=44899163

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP201300004A EE201300004A (et) 2010-07-15 2011-07-15 Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks

Country Status (23)

Country Link
US (1) US8703124B2 (et)
EP (1) EP2593482A2 (et)
JP (1) JP2013532183A (et)
KR (1) KR20140009110A (et)
AR (1) AR084707A1 (et)
AU (1) AU2011278039B2 (et)
BR (1) BR112013000779A2 (et)
CA (1) CA2804969A1 (et)
DE (1) DE112011102356T5 (et)
DK (1) DK201370080A (et)
EA (1) EA201300128A1 (et)
EE (1) EE201300004A (et)
FI (1) FI20135145L (et)
FR (1) FR2962654A1 (et)
GB (1) GB2496795A (et)
IT (1) ITTO20110640A1 (et)
MX (1) MX2013000544A (et)
NO (1) NO20130217A1 (et)
PH (1) PH12013500111A1 (et)
SE (1) SE1350177A1 (et)
SG (1) SG187034A1 (et)
UA (1) UA114699C2 (et)
WO (1) WO2012007846A2 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
ES2440393R1 (es) 2010-07-15 2014-10-10 Oleg Iliich Epshtein Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo
AU2011287288A1 (en) 2010-07-15 2013-03-07 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
AU2011281244A1 (en) 2010-07-21 2013-03-07 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
JP5239899B2 (ja) 2008-07-29 2013-07-17 株式会社リコー 画像形成装置

Also Published As

Publication number Publication date
MX2013000544A (es) 2013-10-28
JP2013532183A (ja) 2013-08-15
BR112013000779A2 (pt) 2016-06-07
EA201300128A1 (ru) 2013-12-30
NO20130217A1 (no) 2013-03-22
DK201370080A (en) 2013-02-14
EP2593482A2 (en) 2013-05-22
WO2012007846A2 (en) 2012-01-19
AR084707A1 (es) 2013-06-05
PH12013500111A1 (en) 2017-07-26
KR20140009110A (ko) 2014-01-22
UA114699C2 (uk) 2017-07-25
SG187034A1 (en) 2013-02-28
FR2962654A1 (fr) 2012-01-20
FI20135145A7 (fi) 2013-02-15
SE1350177A1 (sv) 2013-04-12
AU2011278039B2 (en) 2015-07-23
ITTO20110640A1 (it) 2012-01-16
GB2496795A (en) 2013-05-22
CA2804969A1 (en) 2012-01-19
US8703124B2 (en) 2014-04-22
US20120251584A1 (en) 2012-10-04
GB201302656D0 (en) 2013-04-03
DE112011102356T5 (de) 2013-04-18
FI20135145L (fi) 2013-02-15
WO2012007846A3 (en) 2012-04-12
AU2011278039A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
LT3470063T (lt) Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
IL245328A0 (en) Pharmaceutical composition
LT3400944T (lt) Ibat inhibitoriai, skirt kepenų ligų gydymui
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
EP2646006A4 (en) ARZNEIMITTELDARREICHUNGSFORM
FI20105641A0 (fi) Uusi menetelmä mikroselluloosan valmistamiseksi
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
DK2652652T3 (da) Medikmentadministration
GT201200303A (es) Formulaciones farmacéuticas
EE201300005A (et) Ravimkoostis
EP2544753A4 (en) CATHETER ARRANGEMENT
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
EP2642979A4 (en) PHARMACEUTICAL COMPOSITION
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
EP2815752A4 (en) ORAL PHARMACEUTICAL COMPOSITION
CO6801722A2 (es) Composiciones farmacéuticas
EP2815753A4 (en) ORAL PHARMACEUTICAL COMPOSITION
SMT201500005B (it) Composizione framaceutica inalabile
EP2533763C0 (de) Dermatologische, pharmazeutische zusammensetzung geeignet für oligonukleotide
IT1397838B1 (it) Composizione per la cura delle piante
EP2635307A4 (en) PHARMACEUTICAL COMPOSITIONS